Sprint Bioscience AB (publ) (STO:SPRINT)

Sprint Bioscience AB Revenue

Sprint Bioscience AB had revenue of 153.28M SEK in the twelve months ending March 31, 2026, up 145.72% year-over-year. In the year 2025, Sprint Bioscience AB had annual revenue of 167.39M with 153.07% growth.

• Revenue (ttm): 153.28M
• Revenue Growth: +145.72%
• P/S Ratio: 2.60
• Revenue / Employee: 5.11M
• Employees: 30
• Market Cap: 397.79M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	167.39M	101.24M	153.07%
Dec 31, 2024	66.14M	14.46M	27.97%
Dec 31, 2023	51.69M	51.60M	62,171.08%
Dec 31, 2022	83.00K	-34.95M	-99.76%
Dec 31, 2021	35.03M	15.83M	82.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error